Compare Amphastar Pharmaceuticals Inc (AMPH) vs iShares Semiconductor ETF (SOXX) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

SOXX trades at $581.13, down 0.1% with neutral technical signals. The semiconductor ETF has surged 93.3% YTD through July 6, 2026, driven by AI demand, but faces recent volatility with an 11% drop over the past week. Moving averages remain bullish while oscillators signal neutrality. Key support sits at $576 with resistance at $591.

Outlook remains mixed with strong AI-driven growth potential offset by near-term volatility. Michael Burry's short position and hedge fund selling create headwinds, while JPMorgan recommends buying the dip. The sector faces rotation risk as investors may pivot to hyperscalers according to Morgan Stanley analysis.